BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

AnHorn Medicines Co., Ltd.

 

Company Info

Name /AnHorn Medicines Co., Ltd.

Address /National Biotechnology Research Park C522, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei 115, Taiwan (R.O.C.)

Website /www.anhornmed.com

Presenter

Name /Chih Ming Chen

Title /Vice President of Biology

Email /cmchen@anhornmed.com

Telephone /(Work) 02-2786-2568 #161

Fax /02-2786-2568#3366

Mobile /

Company Type

Biotechnology

About the Company

AnHorn Medicines is a novel drug discovery company with a strong pipeline, offering therapies that Target and Degrade disease-causing proteins. Our mission is to develop new class of BIGPRO® (Bi-functional liGand induced PROteolysis) drugs under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases.

Brief Description of main products or services

AnHorn Medicines focus on novel therapies for cancer, neurodegeneration, and aging diseases by applying AnHorn’s proprietary AIMCADD® platform. We are turning innovation into new therapeutics – new opportunities to target difficult-to-treat and drug resisting diseases.

AnHorn’s Drug Development Strategy:

  • Focuses on discovering BIGPRO® new drugs
  • Develops novel E3 ligase and its ligand
  • Expands unexplored therapeutic opportunity in undruggable targets
  • Establishes a multilayer patent protection framework for projects

Contact Person

Name /Wendy Lin

Email /ywlin@anhornmed.com

Phone /02-2786-2568 #166